TCTMD’s Top 10 Most Popular Stories for October 2022
Our most-read stories ranged from embolic protection and radial CABG to methamphetamines and plant-based eating.
The only common thread uniting our most popular stories this month is that they reflect the breadth and scope of the research in cardiology today. Our daily news and features covered topics that ranged from methamphetamines and atrial fibrillation (AF) to plant-based eating and heart failure, cardiovascular risk factors in COVID-19, and the need for an interventional cardiology fellowship match. Enjoy!
Experts discuss how the results were conveyed and what they mean for embolic protection during TAVI moving forward.
A longitudinal analysis of nearly 24 million California patients shows a relationship between current use and future risk.
The antiviral treatment for COVID-19 is effective but may interact with other drugs in potentially dangerous ways.
These rates are only one metric, but they point to a deeper problem, one that’s likely worse in cardiology, says Sunil Rao.
The phone’s sensors captured the intensity of movement and may be best suited to conditions like congestive heart failure or chronic obstructive pulmonary disorder.
These long-term data from CSP 474 will add fuel to the debate over multiarterial grafting, as recommended by guidelines.
Especially for patients hospitalized for the virus, the months postdischarge are a vulnerable period, says Kevin Clerkin.
The study should spur research on whether upping dietary plant omega-3s reduces death and hospitalization, one expert says.
A match could increase fairness and give applicants more time to decide on their futures, even it means added fees.
While FFR/iFR is recommended in PCI, its utility in surgery, where complete revascularization is more common, was unclear.